Emerging markets deeper submerged
There is no denying that emerging markets have had a difficult year. Investor sentiment towards EMs has deteriorated, EM currencies have weakened by 10-15% across the EM complex, and falling equity prices have added to the misery.
Emerging Markets Equity is down 21.9% since January highs
MSCI Emerging Markets Index USD
Source: New York Life Investments; Thompson Reuters Datastream; MSCI, 10/10/18. MSCI Emerging Markets Index, USD accounts for changes to the index in dollar terms, meaning it incorporates currency impacts. Past performance is no guarantee of future results, which will vary. It is not possible to invest directly in an index.
While redemptions out of EMs have been heavy, there are reasons to believe that the EM complex is oversold. For starters, most countries’ economic fundamentals have not materially weakened leading up to or through the selloff. While portfolio outflows have been meaningful, capital outflows – business investment in on-the-ground economic capacity – have been well within normal ranges. One reason for this is that multinational corporations are accustomed to currency and market volatility in less-developed countries and tend to take a “wait and see” approach to their business rather than abruptly change their international investment plans.
What’s more, price divergence between U.S. and emerging market equities is extreme. The 65-day performance spread between the S&P 500 Index and the MSCI Emerging Markets Index is flirting with the 5th percentile of all historical observations, suggesting that some mean reversion is likely.
At this time, we consider it unlikely that emerging markets issues will worsen substantially or propagate to the global financial system.
Substantial short-term risks remain
Still, the global economic dynamics driving portfolio outflows have worsened since we last posted on the topic. Indeed, trade protectionism has increased since the summer, as conciliatory tones with Europe, South Korea, and North America have been matched by the Trump Administration’s demonstrated willingness to impose additional tariffs on China. Trade measures would have to worsen (e.g. higher tariffs) and stay in effect for an extended period to materially impact global economic growth, but this remains a distinct possibility. Adding to this dynamic is the fact that China’s economic growth – which is already experiencing a managed slowdown – is intrinsically tied to the success of other emerging markets economies, notably through commodities exports. If China sneezes, then other emerging markets are more likely to catch a cold.
Central banks shifting from quantitative easing to quantitative tightening is redirecting capital flows and driving up debt capital costs within the EM complex. In addition, the dollar has remained strong relative to emerging markets currencies, which can be problematic for countries with significant external financing needs or large dollar-denominated debt balances. To add a fourth complicated factor, oil prices have risen, which can stabilize government coffers for energy exporting economies, but worsen external liabilities for energy importers – namely Argentina and Turkey.
The past couple of weeks have reinforced that markets can sell off even when economic fundamentals are positive. Business activity and earnings are strong, but prices take expectations for growth into account, and global growth is likely to be lower in the future than it has been in the past 12-18 months. Despite our high conviction belief that emerging market equities will perform well over an extended period, we are only modestly overweight emerging markets economies at present, less so than earlier in the year, as we are mindful of the potential for protectionism to yet inflict material harm.
The interconnected contributors to global portfolio and capital flows will continue to obscure the emerging markets story. Relative economic performance across countries and currency dynamics will play a particularly strong role and are difficult to time. Investors should seek alpha exposure in emerging markets, not beta exposure. Active management thus remains a prudent consideration across the emerging markets complex.
The information and opinions contained herein are for general information use only. New York Life Investments does not guarantee their accuracy or completeness, nor does New York Life Investments assume any liability for any loss that may result from the reliance by any person upon any such information or opinions. Such information and opinions are as of the date of this report, are subject to change without notice, and are not intended as an offer or solicitation with respect to the purchase or sales of any security or as personalized investment advice. There can be no guarantee that any projection, forecast, or opinion in this material will be realized.
All investments are subject to market risk, including possible loss of principal. Stocks and bonds can decline due to adverse issuer, market, regulatory, or economic developments. Bonds are also subject to credit risk, in which the bond issuer may fail to pay interest and principal in a timely manner, or that negative perception of the issuer’s ability to make such payments may cause the price of that bond to decline. A bond’s prices are inversely affected by interest rates. The price will go up when interest rates fall and go down as interest rates rise.
Foreign securities can be subject to greater risks than U.S. investments, including currency fluctuations, less liquid trading markets, greater price volatility, political and economic instability, less publicly available information, and changes in tax or currency laws or monetary policy. These risks are likely to be greater for emerging markets than in developed markets.
Index performance is shown for illustrative purposes only and does not predict or depict the performance of the Funds. Indices are unmanaged, include the reinvestment of dividends, and cannot be purchased directly by investors. Past performance does not guarantee future results.
International Monetary Fund – an international organization that promotes the stabilization of the world’s currencies and maintains a monetary pool from which member nations can draw in order to correct a deficit in their balance of payments: a specialized agency of the United Nations.
The MSCI Emerging Markets Index is an index created by Morgan Stanley Capital International (MSCI) designed to measure equity market performance in global emerging markets.
The MSCI World ex USA Index captures large and mid-cap representation across 22 of 23 Developed Markets (DM) countries*–excluding the United States. With 1,016 constituents, the index covers approximately 85% of the free float-adjusted market capitalization in each country.
The S&P 500 Index is an unmanaged index and is widely regarded as the standard for measuring large-cap U.S. stock-market performance. Index results assume the reinvestment of all capital gain and dividend distributions. An investment cannot be made directly into an index.
Quantitative easing is an unconventional monetary policy in which a central bank purchases government securities or other securities from the market in order to lower interest rates and increase the money supply.
New York Life Investments® is a registered service mark and name under which New York Life Investment Management LLC does business. New York Life Investments, an indirect subsidiary of New York Life Insurance Company, New York, NY 10010, provides investment advisory products and services. Securities distributed by NYLIFE Distributors LLC, 30 Hudson Street, Jersey City, NJ 07302.